Article info
Commentary
Safety and efficacy of the subdermal etonogestrel contraceptive implant Implanon®
- Correspondence to Dr Rob Beerthuizen, Dutch Foundation for Contraception, B. Stegemanstraat 28, Winterswijk 7101AS, The Netherlands; beerthuizen{at}anticonceptie-online.nl
Citation
Safety and efficacy of the subdermal etonogestrel contraceptive implant Implanon®
Publication history
- Received September 28, 2016
- Revised November 7, 2016
- Accepted November 9, 2016
- First published December 13, 2016.
Online issue publication
April 11, 2017
Article Versions
- Previous version (13 December 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/